Edesa Biotech to Participate in Upcoming Canaccord Genuity Growth Conference

Published on July 26, 2023

TORONTO, ON / ACCESSWIRE / July 26, 2023 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, announced today that the company will participate in a Fireside Chat and host one-on-one meetings at the Canaccord Genuity 43rd Annual Growth Conference being held in Boston from August 7-10, 2023.

The Fireside Chat discussion between Edesa's Chief Executive Officer, Par Nijhawan, MD, and a Canaccord analyst is scheduled to take place on Thursday, August 10, 2023 at 12:00 pm ET, and is open to those who are registered to attend the event. To schedule a meeting with Edesa during the conference, please contact your Canaccord representative or the company directly at [email protected].

 

Continue reading on website
Other news

Investment of $5.2 Million Supports STEM Grads in Green Economy

July 25, 2023
OTTAWA, ON — BioTalent Canada is pleased to announce that it has reopened its popular Science Horizons program that provides employers in the environmental and clean-technology sectors with wage subsidies to hire post-secondary STEM graduates.The program has been run by BioTalent Canada for several years and has been well-received by many bio-economy employers. The reopening of the Science Horizon

Infinity lays off 78% of staff, 3 board members after MEI merger fails

July 26, 2023
With hopes of a merger with MEI Pharma now sunk for good, Infinity Pharmaceuticals is jettisoning three-quarters of its staff and three board members to stay afloat while it scans the horizon for another financial life raft.The planned combination of MEI Pharma and Infinity had been in the works since February. Yet despite surviving the intervention of a surprise bidder at the last minute, MEI’s s